ALI-AKBAR SHAHINE: Open Payments
NPI 1891337812 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,299 in 123 payments from 16 companies in 2025. Trend: 2023 $2,082 · 2024 $4,339 · 2025 $3,299
Food & beverage: $3,040Education: $259
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 20 | $817 |
| Janssen Biotech, Inc. | 17 | $375 |
| ABBVIE INC. | 18 | $341 |
| UCB, Inc. | 7 | $337 |
| Incyte Corporation | 10 | $220 |
| Regeneron Healthcare Solutions, Inc. | 7 | $215 |
| PFIZER INC. | 11 | $205 |
| Arcutis Biotherapeutics, Inc. | 7 | $139 |
| Lilly USA, LLC | 5 | $137 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $137 |
Products named: DUPIXENT, TREMFYA, Bimzelx, OPZELURA, CIBINQO, SKYRIZI, RINVOQ, Zoryve.
Industry payments across CA — which companies pay providers there.
